abstract |
The present invention relates to low molecular weight compounds, including compounds of Formulas I and II as defined herein, and pharmaceutical compositions thereof, useful as modulators of CCR- 5 activity. The invention further relates to the use of such compounds and compositions in treating disorders mediated by CCR-5 such as viral infections and inflammatory diseases. |